• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep strongest adhd medication for adults medications during pregnancy and breastfeeding is a difficult decision for women suffering from the condition. Little data exists about how long-term exposure to these drugs could affect the foetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge that further high-quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication need to weigh the benefits of taking it versus the risks for the baby. Physicians don't have the data to make unambiguous recommendations, but can provide information about risks and benefits to assist pregnant women to make an informed decision.

A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not face a significantly increased risk of fetal cardiac malformations or major structural birth defects. Researchers conducted a large, population-based case-control study to determine the prevalence of major structural birth defects in babies born to mothers who had taken stimulants in the early stages of pregnancy, as well as those who had not. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure correct case classification and to limit the chance of bias.

However, the researchers' study had its limitations. The researchers were not able in the beginning, to separate the effects triggered by the medication from the disorder. That limitation makes it difficult to determine whether the limited associations observed in the exposed groups are due to the use of medication or the confounding effect of comorbidities. In addition the researchers did not study the long-term effects of offspring on their parents.

The study found that infants whose mother took ADHD medication during pregnancy were at a slightly higher risk of admission to the neonatal care unit (NICU) in comparison to those whose mothers didn't take any medication during pregnancy, or had stopped taking their medication before or during pregnancy. The reason for this was central nervous system disorders, and the increased risk for admission was not found to be affected by the type of stimulant medications were taken during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher likelihood of having caesarean sections or the baby was not scoring well on the Apgar scale (less than 7). These increases appear to be independent of the type of medication taken during pregnancy.

The researchers suggest that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy could be offset by the higher benefit to both mother and child of continuing treatment for the woman's condition. Doctors should discuss with their patients about this issue and try to help them develop coping skills that could reduce the impact of her disorder in her daily life and relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and being treated with medication, the question of whether to keep or end treatment during pregnancy is a question that more and more physicians confront. These decisions are often taken without clear and authoritative evidence. Instead, doctors must weigh their own knowledge, the experience of other physicians and the research on the subject.

The issue of risk to the infant can be difficult to determine. The research on this subject is based on observation rather than controlled studies, and a lot of the results are contradictory. In addition, most studies limit their analysis to live births, which adhd medication is the best can underestimate severe teratogenic effects that lead to abortion or termination of the pregnancy. The study discussed in the journal club addresses these issues, by examining both the data from deceased and live births.

Conclusion: While some studies have found an association between ADHD medications and certain birth defects however, other studies haven't found a correlation. Most studies show that there is a neutral, or slight negative effect. In all cases, a careful evaluation of the potential risks and benefits should be conducted.

For many women with ADHD, the decision to discontinue medication can be difficult, if not impossible. In fact, in an article published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can you get adhd medication without a diagnosis cause depression, feelings of loneliness, and family conflict for these patients. A loss of medication may also affect the ability to drive safely and complete work-related tasks, which are crucial aspects of everyday life for those with liquid adhd medication uk.

She suggests that women who are unsure about whether to continue or stop taking medication because of their pregnancy should consider the possibility of educating friends, family members and colleagues about the condition, its effects on daily functioning, and on the benefits of keeping the current treatment regimen. It can also help a woman feel more confident in her decision. Certain medications can be passed through the placenta. If the patient decides to stop taking her ADHD medication while breastfeeding, it's important to be aware that the drug could be passed on to her baby.

Birth Defects Risk

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns about the effects that the drugs could have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this topic. Researchers used two huge data sets to examine over 4.3 million pregnancies and determine if stimulant medication use caused birth defects. Researchers found that while the overall risk is low, the first trimester ADHD medication use was associated with slightly higher rates of specific heart defects such as ventriculoseptal defect.

The researchers of the study could not find any association between early use of medication and congenital anomalies such as facial deformities or club feet. The results are consistent with previous studies showing the presence of a small, but significant increase in the risk of cardiac malformations in women who started taking ADHD medications prior to the time of pregnancy. The risk was higher in the latter half of pregnancy, when a lot of women are forced to stop taking their medication.

Women who were taking ADHD medication in the first trimester were more likely to require a caesarean delivery, have a low Apgar after delivery, and have a baby who needed breathing assistance when they were born. However the researchers of the study were unable to eliminate bias due to selection by limiting the study to women who did not have any other medical conditions that could be a contributing factor to these findings.

Researchers hope that their study will inform physicians when they encounter pregnant women. The researchers advise that, while discussing benefits and risks are important, the decision about whether to continue or stop taking medication should be according to the severity of each woman's ADHD symptoms and her needs.

The authors caution that, while stopping the medication is an option to look into, it is not recommended due to the high rate depression and other mental problems for women who are pregnant or who have recently given birth. Further, research shows that women who stop taking their medication will have a tough adjustment to life without them once the baby is born.

Nursing

It can be a challenge becoming a mother. Women who suffer from ADHD are often faced with a number of difficulties when they have to manage their symptoms, go to doctor appointments and prepare for the birth of their child and adjust to a new adhd medication routine. This is why many women choose to continue taking their ADHD medications throughout pregnancy.

The risk to a nursing infant is low because the majority of stimulant medication passes through breast milk in low amounts. The amount of exposure to medications can vary depending upon the dosage and frequency of administration as well as the time of day. Additionally, individual medications enter the infant's system differently through the gastrointestinal tract and breast milk. The impact of this on a newborn isn't yet fully known.

Due to the absence of research, some physicians may be inclined to discontinue stimulant medications during the pregnancy of a woman. This is a difficult decision for the woman, who must weigh the benefits of continuing her medication against the risks to the foetus. Until more information becomes available, doctors may ask pregnant patients whether they have any history of ADHD or if they are planning to take medication during the perinatal period.

Many studies have shown that women can continue to take their ADHD medication without risk while breastfeeding and during pregnancy. In response, a growing number of patients are opting to do so. They have concluded after consulting with their doctor, that the benefits of keeping their current medication outweigh possible risks.

It's important for women with Cheapest Adhd Medication who are considering breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should review their medications with their physician and discuss the advantages and disadvantages of continued treatment, including non-pharmacological strategies. Psychoeducation should also be offered to help women with ADHD be aware of their symptoms and the underlying disorder, learn about available treatment options and reinforce existing coping strategies. This should be a multidisciplinary effort with the GPs, obstetricians and psychiatry. Pregnancy counseling should include a discussion of a treatment plan for the mother and the child, and monitoring for signs of deterioration and, if necessary adjustments to the medication regimen.